Background
Aggregate global data from high-income countries have shown a significant decline in incidence for both ischemic and hemorrhagic stroke between 1990 and 2010.Reference Krishnamurthi, Feigin and Forouzanfar1,Reference Li, Scott and Rothwell2 However, there is variability among individual countries, as well as concerning reports of rising stroke incidence in younger individuals in recent years.Reference Krishnamurthi, Feigin and Forouzanfar1,Reference Kissela, Khoury and Alwell3-Reference Seminog, Scarborough, Wright, Rayner and Goldacre5 We aimed to evaluate recent temporal trends in acute stroke incidence over a 15-year period from an entire province in Canada.
Methods
Study Sample and Data Sources
The province of Ontario had an adult population of approximately 9.5 million in 2003 and 11.3 million in 2017. The province has universal healthcare for residents, covering all costs for hospitalizations and emergency department (ED) visits. We used administrative data to identify all patients with ischemic stroke and intracerebral hemorrhage (ICH) admitted to an acute care hospital or seen in the ED in Ontario, Canada between fiscal years 2003 (starting April 1, 2003) and 2017 (ending March 31, 2018). The datasets were linked using unique encoded identifiers and analyzed at ICES (formerly known as the Institute for Clinical Evaluative Sciences). Cases were ascertained with the Canadian Institutes for Health Information - Discharge Abstract Database for hospital admissions and the Canadian Institutes for Health Information - National Ambulatory Care Reporting System for ED visits using International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Canada (ICD-10-CA) codes [ischemic stroke: I63.x (excluding I63.6), I64.x, H34.1; intracerebral hemorrhage: I61.x]. The transition from ICD-9 to ICD-10 was complete in 2002 in Ontario. These codes have been validated through duplicate chart abstraction, with excellent positive predictive value for stroke in Canada.Reference Porter, Mondor, Kapral, Fang and Hall6 By law, all ED visits and admissions to hospital are included in these databases. We excluded patients with subarachnoid hemorrhage and cerebral venous sinus thrombosis, those <18 or >104 years of age, with elective admissions, and death before arrival to the ED. We also excluded those with in-hospital stroke due to substantial differences in baseline characteristics and stroke severity compared to community-onset stroke.Reference Saltman, Silver, Fang, Stamplecoski and Kapral7 We identified transfers between institutions to link together the same episodes of care and avoid duplication of records. We established a 12-year wash-out period between 1991 and 2002 and excluded any individuals with prior stroke in that time (using ICD-10-CA codes above in addition to I60 [subarachnoid hemorrhage], and ICD-9 codes 430, 431, 434, and 436).
We estimated stroke severity for hospitalized patients using linked administrative data according to previously described methods for the PaSSV indicator (excluding the Canadian Triage and Acuity Scale as it may not generalize to other jurisdictions).Reference Yu, Austin and Rashid8 See Supplementary Table for additional data sources and algorithms used.Reference Shah, Chiu, Amin, Ramani, Sadry and Tu9-Reference Schultz, Rothwell, Chen and Tu13
Analysis
We assessed for trends in baseline characteristics across the study period using the Cochrane–Armitage test for proportions and linear regression for means. We computed crude and age-/sex-standardized acute stroke incidence rates per 100,000 person-years for each fiscal year from 2003 to 2017 using the 2003 Ontario population as the standard, overall and stratified by stroke type. We also computed age-standardized incidence rates in women and men, and sex-standardized rates stratified by age group (<60, 60–79, and 80+ years). We evaluated the statistical significance of trends in standardized rates using the Kendall τ-b correlation coefficient, with a threshold of p = 0.05. We used negative binomial regression to assess the association between year since 2003 and incidence, assessing for modification by age, sex, and stroke type. Due to significant modification by age, we fit models to obtain annual incidence rate ratios (IRRs) separately for each age group, adjusting for sex and stroke type. We performed an additional analysis also adjusting for estimated stroke severity among hospitalized patients. Analyses were conducted using SAS Enterprise Guide 7.1 (Cary, NC) and Stata 16.0 (College Station, TX).
Results
There were 163,574 people with incident acute stroke in the final cohort, 87.6% of whom had ischemic stroke. Baseline characteristics across years in the whole cohort are shown in Table 1. There were increases in the proportions of people aged <60 years, those with hypertension and diabetes, and a decrease in the proportion of women over the study period. The number of incident strokes remained stable from 2003 to 2011 (10,295 to 10,148), then rose by approximately 33% until 2017 (13,476).
SD indicates standard deviation, CHF congestive heart failure, CAD coronary artery disease. Estimated severity (PaSSV indicator) was derived using linked administrative data, with higher score indicating lower probability of severe stroke.
Among all strokes, there was a gradual decrease in age-/sex-standardized incidence by 21.6% between 2003 and 2011 (standardized rate 109.4 to 85.8 per 100,000), followed by a reversal and continuous increase of 12.7% between 2011 and 2017 (standardized rate 96.8 per 100,000; Kendall τ-b correlation coefficient −0.33, p = 0.08). The pattern was similar for ischemic stroke and ICH, men and women, and those aged 60 years and over (Figure 1A-C and Supplementary Figure 1 A-D). In contrast, there was a continuous rise in incidence for individuals <60 years from 2003 to 2017 (Kendall τ-b 0.89, p < 0.001; Figure 1D and Supplementary Figure 1E-F).
Yearly trends in acute stroke incidence were modified by age (p < 0.001 for interaction), but not sex or stroke type. While adjusted IRRs for those aged over 60 years declined from 2003 to 2011 then stabilized and increased, IRRs for individuals <60 increased throughout the entire study period and especially after 2011 (Figure 2). The IRR trends were unchanged after adjustment for estimated stroke severity among hospitalized patients. Patterns were also similar for men and women (Supplementary Figure 2).
Discussion
In this population-based study, we found that a decline in stroke incidence between 2003 and 2011 was followed by an increase in incidence between 2011 and 2017, for both ischemic stroke and ICH and for men and women. Stroke incidence increased over the entire study period among those aged under 60 years.
The decreasing incidence of ischemic stroke and ICH in the first half of our study period is consistent with many prior studies.Reference Li, Scott and Rothwell2,Reference Zahuranec, Lisabeth and Sánchez14 However, the increase in incidence between 2011 and 2017 is an unexpected finding, and there are few population-based studies for comparison due to the recency of the observation window. An update from the Atherosclerosis Risk in Communities Cohort in the United States demonstrated a continuous drop in overall stroke incidence from 1990 to 2017, although the study had no individuals <65 years old after 2010.Reference Koton, Sang, Schneider, Rosamond, Gottesman and Coresh15
Possible explanations for our findings include improved detection of minor stroke, or differences in care-seeking behavior over the study time period. However, we included both stroke hospitalizations and ED visits, and there was no change in trends after adjustment for estimated stroke severity among hospitalized patients, reducing the likelihood that our findings were due to changes in admission thresholdsReference Kamal, Lindsay, Côté, Fang, Kapral and Hill16,Reference Botly, Lindsay and Mulvagh17 and raising the possibility of a true increase in stroke incidence. Rates of vascular risk factors, particularly diabetes and obesity, are increasing in Canada overall but especially among younger individuals.Reference Manuel, Tuna and Hennessy18,Reference Lee, Chiu and Manuel19 The rise in stroke incidence in our study was particularly striking among young adults, confirming and extending prior observations.Reference Kissela, Khoury and Alwell3,Reference Rosengren, Giang, Lappas, Jern, Torén and Björck4,Reference Madsen, Khoury and Leppert20 The possibility of changes in other stroke risk factors characteristic of young age, such as recreational drug use, exogenous hormone use, or cervical artery dissection, should also be considered. Although strokes in individuals less than 60 years of age accounted for only 17% of all strokes in our cohort, our finding of a consistent increase in incidence over 15 years is concerning given the potential for greater number of years lived with disability.
Limitations of our study include those inherent to the use of administrative data. We did not have imaging confirmation or physician adjudication of stroke, although the case definitions used have high validity in Canada.Reference Porter, Mondor, Kapral, Fang and Hall6 We could not assess outpatient visits for stroke due to low specificity of outpatient claims data for strokeReference Tu, Wang and Young21; although this would reduce ascertainment of minor stroke it would not explain the pattern of change we observed. We did not include out-of-hospital deaths from stroke due to inability to differentiate ischemic stroke from ICH and we could not determine stroke etiology. Despite these limitations, our study is strengthened by the complete ascertainment of events requiring hospitalization or ED care in a large population.
The observed increase in stroke incidence between 2011 and 2017 suggests the need for research to understand the underlying drivers of this finding, especially among younger individuals, and to determine if these changes are occurring in other jurisdictions.
Acknowledgements
This study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario Ministry of Health and Long-Term Care is intended or should be inferred. Parts of this material are based on data and/or information compiled and provided by the Canadian Institute for Health Information. However, the analyses, conclusions, opinions and statements expressed in the material are those of the author(s), and not necessarily those of the Canadian Institute for Health Information.
RAJ is supported by a Fellowship Grant from the Canadian Institutes of Health Research. AYXY is supported by the Heart & Stroke Foundation of Canada National New Investigator Award. MKK is supported by a Mid-Career Investigator Award from the Heart and Stroke Foundation of Canada and holds the Lillian Love Chair in Women’s Health from the University Health Network/University of Toronto.
Funding
The study was supported by the Physicians’ Services Incorporated Foundation.
Disclosures
EES reports royalties from UpToDate, consulting fees from Alnylam, Biogen, and Javelin. The remaining authors have no conflicts of interest to declare.
Statement of Authorship
RAJ was involved with conception, design, analysis, interpretation, and drafting the manuscript.
EES was involved with conception, design, interpretation, and critical revision of the manuscript.
AYXY was involved with design, interpretation and critical revision of the manuscript.
MR and JF were involved with data acquisition and analysis.
MKK was involved with conception, design, interpretation, and critical revision of the manuscript.
Supplementary Material
To view supplementary material for this article, please visit https://doi.org/10.1017/cjn.2020.257.